Filter News
Area of Research
News Topics
- (-) Biomedical (4)
- (-) Isotopes (4)
- (-) ITER (1)
- (-) Neutron Science (6)
- (-) Nuclear Energy (2)
- 3-D Printing/Advanced Manufacturing (7)
- Artificial Intelligence (2)
- Big Data (1)
- Bioenergy (1)
- Biology (5)
- Biotechnology (1)
- Buildings (4)
- Chemical Sciences (4)
- Climate Change (1)
- Composites (3)
- Computer Science (9)
- Coronavirus (4)
- Critical Materials (2)
- Cybersecurity (3)
- Decarbonization (1)
- Energy Storage (9)
- Environment (3)
- Frontier (3)
- Fusion (5)
- Grid (3)
- High-Performance Computing (5)
- Machine Learning (1)
- Materials (10)
- Materials Science (8)
- Microscopy (4)
- Nanotechnology (5)
- National Security (3)
- Physics (1)
- Polymers (3)
- Quantum Computing (3)
- Quantum Science (5)
- Security (1)
- Summit (5)
- Sustainable Energy (6)
- Transportation (4)
Media Contacts
In experiment after experiment, the synthetic radioisotope actinium-225 has shown promise for targeting and attacking certain types of cancer cells.
A team including researchers from the Department of Energy’s Oak Ridge National Laboratory has developed a digital tool to better monitor a condition known as Barrett’s esophagus, which affects more than 3 million people in the United States.
ORNL's Larry Baylor and Andrew Lupini have been elected fellows of the American Physical Society.
ASM International recently elected three researchers from ORNL as 2021 fellows. Selected were Beth Armstrong and Govindarajan Muralidharan, both from ORNL’s Material Sciences and Technology Division, and Andrew Payzant from the Neutron Scattering Division.
Scientists at ORNL and the University of Tennessee, Knoxville, have found a way to simultaneously increase the strength and ductility of an alloy by introducing tiny precipitates into its matrix and tuning their size and spacing.
Kathy McCarthy, associate laboratory director for Fusion and Fission Energy and Science at the Department of Energy’s Oak Ridge National Laboratory, has been elected fellow of the American Nuclear Society for her nationally and internationally recognized leadership in nuclear energy and fusion.
The Department of Energy’s Office of Science has selected five Oak Ridge National Laboratory scientists for Early Career Research Program awards.
A rare isotope in high demand for treating cancer is now more available to pharmaceutical companies developing and testing new drugs.
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.
Ken Andersen has been named associate laboratory director for the Neutron Sciences Directorate, or NScD, at the Department of Energy’s Oak Ridge National Laboratory.